• S02E04 Beyond the surface Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial

  • Aug 15 2022
  • Duración: 10 m
  • Podcast

S02E04 Beyond the surface Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial Por arte de portada

S02E04 Beyond the surface Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Beyond the surface. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial

    A modern landmark glaucoma trial and first-of-its-kind that provides surprising and useful outcomes for current practice and research. Can the visual field be preserved with an intraocular-pressure-lowering drug in patients with open-angle glaucoma? Dr Jennifer Fan Gaskin explores Latanoprost for open-angle glaucoma.

    View article here

    Jennifer Fan Gaskin is a Consultant Ophthalmologist at the Royal Victorian Eye and Ear Hospital and a Principal Investigator at the Centre for Eye Research Australia where she leads Ocular Fibrosis Research. In 2021 she was named a Superstar of STEM by Science and Technology Australia. She is a Director of Australian Vision Research (formerly known as the Ophthalmic Research Institute of Australia) and a board member of the Australian and New Zealand Glaucoma Society.
    Más Menos
activate_primeday_promo_in_buybox_DT
Más Menos

Lo que los oyentes dicen sobre S02E04 Beyond the surface Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles